Skip to content

Why Kratom Is At The Heart Of A Big Public Health Debate

Short Wave

Hosted by Emily Kwong

12m
Transcript

Original podcast

About this episode

Kratom and 7-OH products are available in many smoke shops. But earlier this year, the FDA recommended certain 7-OH products be scheduled alongside opioids. This isn’t the first time kratom has come under scrutiny. Nearly a decade ago, the DEA wanted to make certain active ingredients in kratom controlled substances. Meaning products would go from being widely available to highly restricted. After a massive wave of protest, the DEA decided not to move forward. Producer Rachel Carlson https://www.npr.org/people/1112796909/rachel-carlson joins host Emily Kwong https://www.npr.org/people/767284140/emily-kwong to talk about what could happen this time around, and what scientists know – and don’t know – about kratom and 7-OH. Interested in more of the science behind drugs and supplements? Email us your question at [email protected] mailto:[email protected]. Listen to every episode of Short Wave sponsor-free and support our work at NPR by signing up for Short Wave+ at plus.npr.org/shortwave http://plus.npr.org/shortwave. See pcm.adswizz.com https://pcm.adswizz.com for information about our collection and use of personal data for sponsorship and to manage your podcast sponsorship preferences. NPR Privacy Policy https://www.npr.org/about-npr/179878450/privacy-policy

Transcript

0:00
12:53

2,325 words · 9 speakers

Speaker names marked are inferred from speaking time and the show’s known hosts — they are not voice-verified.

Page updated · transcript and summary are machine-generated